Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Maravai Lifesciences Holdings Inc Cl A (NQ: MRVI )

7.970 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 7.970
Bid (Size) 7.680 (1)
Ask (Size) 11.89 (1)
Prev. Close 7.970
Today's Range 7.970 - 7.970
52wk Range 4.520 - 11.55
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unveiling 4 Analyst Insights On Maravai LifeSciences
Via Benzinga
Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire

Performance

YTD
+18.25%
+18.25%
1 Month
-13.46%
-13.46%
3 Month
-28.20%
-28.20%
6 Month
+45.44%
+45.44%
1 Year
-23.37%
-23.37%

More News

Read More
Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Maravai LifeSciences Reports Second Quarter 2024 Financial Results
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Where Maravai LifeSciences Stands With Analysts
Via Benzinga
Maravai LifeSciences Appoints Trey Martin to Board of Directors
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
From TriLink BioTechnologies
Via Business Wire
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
MRVI Stock Earnings: Maravai LifeSciences Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Maravai LifeSciences Reports First Quarter 2024 Financial Results
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
From TriLink BioTechnologies
Via Business Wire
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
From TriLink BioTechnologies
Via Business Wire
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report
Via AB Newswire
Topics Regulatory Compliance
Exposures Legal Regulatory
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
Via AB Newswire
Exposures Product Safety
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
Via AB Newswire
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI
Via AB Newswire
Nasdaq Edges Lower; AXT Shares Surge After Q4 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
Privacy Policy  |  Terms of Use  |  MNG Corporate Site Map  |  Copyright